![Frontiers | Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma Frontiers | Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma](https://www.frontiersin.org/files/Articles/541869/fonc-10-01263-HTML/image_m/fonc-10-01263-g001.jpg)
Frontiers | Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma
![PDF] Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 by Loris De Cecco, Luigi Marchionni, Manuela Gariboldi, James F. Reid, M. Stefania Lagonigro, PDF] Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 by Loris De Cecco, Luigi Marchionni, Manuela Gariboldi, James F. Reid, M. Stefania Lagonigro,](https://og.oa.mg/Gene%20expression%20profiling%20of%20advanced%20ovarian%20cancer%3A%20characterization%20of%20a%20molecular%20signature%20involving%20fibroblast%20growth%20factor%202.png?author=%20Loris%20De%20Cecco,%20Luigi%20Marchionni,%20Manuela%20Gariboldi,%20James%20F.%20Reid,%20M.%20Stefania%20Lagonigro,%20Stefano%20Caramuta,%20Cristina%20Ferrario,%20Erica%20Bussani,%20Delia%20Mezzanzanica,%20Fabio%20Turatti,%20Domenico%20Delia,%20Maria%20Grazia%20Daidone,%20Maria%20Oggionni,%20Norma%20Bertuletti,%20Antonino%20Ditto,%20Francesco%20Raspagliesi,%20Silvana%20Pilotti,%20Marco%20A.%20Pierotti,%20Silvana%20Canevari,%20Claudio%20Schneider)
PDF] Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 by Loris De Cecco, Luigi Marchionni, Manuela Gariboldi, James F. Reid, M. Stefania Lagonigro,
![Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer](https://cdn.slidesharecdn.com/ss_thumbnails/1471-230x-13-87-130518085407-phpapp02-thumbnail.jpg?width=640&height=640&fit=bounds)
Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer
![Long short-term memory model – A deep learning approach for medical data with irregularity in cancer predication with tumor markers - ScienceDirect Long short-term memory model – A deep learning approach for medical data with irregularity in cancer predication with tumor markers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0010482522001548-gr1.jpg)
Long short-term memory model – A deep learning approach for medical data with irregularity in cancer predication with tumor markers - ScienceDirect
![PDF) Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer PDF) Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer](https://www.researchgate.net/profile/Carolyn-Lammersfeld/publication/47403231/figure/fig2/AS:267610763821059@1440814786131/Survival-Curves-for-2-Categories-of-CA125-at-Baseline_Q320.jpg)
PDF) Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
![Marker nowotworowy CA 125 (antygen nowotworowy CA 125) - Centrum Medyczne Meavita | Kraków, Rusznikarska 14 Marker nowotworowy CA 125 (antygen nowotworowy CA 125) - Centrum Medyczne Meavita | Kraków, Rusznikarska 14](https://meavita.pl/wp-content/uploads/2022/04/Marker-nowotworowy-CA-125.jpeg)
Marker nowotworowy CA 125 (antygen nowotworowy CA 125) - Centrum Medyczne Meavita | Kraków, Rusznikarska 14
![PDF) Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study PDF) Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study](https://www.researchgate.net/profile/Maria-Lee-20/publication/273468139/figure/tbl2/AS:667813429661706@1536230537892/Comparison-of-CA-125-and-neutrophil-to-lymphocyte-ratio-NLR-among-underweight-normal_Q320.jpg)
PDF) Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
![PDF) Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer PDF) Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer](https://www.researchgate.net/profile/Carolyn-Lammersfeld/publication/47403231/figure/fig1/AS:267459299115094@1440778674823/Survival-Curves-for-4-Categories-of-CA125-Change_Q320.jpg)
PDF) Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
![GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas | Scientific Data GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas | Scientific Data](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41597-022-01921-2/MediaObjects/41597_2022_1921_Fig1_HTML.png)
GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas | Scientific Data
![JPM | Free Full-Text | The Female Reproductive Tract Microbiome—Implications for Gynecologic Cancers and Personalized Medicine JPM | Free Full-Text | The Female Reproductive Tract Microbiome—Implications for Gynecologic Cancers and Personalized Medicine](https://pub.mdpi-res.com/jpm/jpm-11-00546/article_deploy/html/images/jpm-11-00546-ag.png?1623850370)
JPM | Free Full-Text | The Female Reproductive Tract Microbiome—Implications for Gynecologic Cancers and Personalized Medicine
![EP2363711A1 - Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor - Google Patents EP2363711A1 - Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor - Google Patents](https://patentimages.storage.googleapis.com/a0/96/27/92c8a017ed62ea/imgb0008.png)